Albrecht A M
Cancer Treat Rep. 1977 Jul;61(4):533-8.
The interrelated enzymic reactions of folate metabolism are presented and key tetrahydrofolate-producing reactions are emphasized. As observed with the methotrexate (MTX)-resistant mutant strain Streptococcus faecium var. durans/Ak, the regulatory roles of serine and purines in controlling their own synthesis by the repression of enzymes required for co-factor synthesis are reviewed. Positive induction of the dihydrofolate reductase activity of this mutant by folate and the antagonism of the folate effect by purines and thymine are discussed. A protective agent of the reductase-active protein, MTX is viewed also as a "positive" inducer of dihydrofolate reductase. Preliminary studies with L1210 leukemia-bearing mice and the murine leukemia ERLD in vitro suggest that citrovorum factor (CF) also triggers a positive induction of the reductase of the small intestine and of ERLD cells without apparently influencing the reductase level of L1210 in vivo. The possibility that control mechanisms, by which MTX and CF indirectly regulate enzyme synthesis in drug-stressed, CF-rescued cells, contribute to the success of high-dose MTX-CF rescue therapy is introduced.
本文介绍了叶酸代谢的相关酶促反应,并着重强调了关键的四氢叶酸生成反应。正如在耐甲氨蝶呤(MTX)的突变菌株粪肠球菌变种杜兰/Ak中所观察到的那样,综述了丝氨酸和嘌呤在通过抑制辅因子合成所需酶来控制自身合成方面的调节作用。讨论了叶酸对该突变体二氢叶酸还原酶活性的正诱导作用以及嘌呤和胸腺嘧啶对叶酸作用的拮抗作用。MTX作为还原酶活性蛋白的保护剂,也被视为二氢叶酸还原酶的“正”诱导剂。对携带L1210白血病的小鼠和体外培养的鼠白血病ERLD进行的初步研究表明,亚叶酸(CF)也能触发小肠和ERLD细胞还原酶的正诱导,而在体内对L1210的还原酶水平没有明显影响。引入了一种控制机制的可能性,即MTX和CF通过该机制间接调节药物应激、CF挽救细胞中的酶合成,这有助于大剂量MTX-CF挽救疗法的成功。